Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Treasury Shares: 2013-2024

Historic Treasury Shares for Fortress Biotech (FBIO) over the last 12 years, with Dec 2024 value amounting to $4.4 million.

  • Fortress Biotech's Treasury Shares rose 185.20% to $5.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.1 million, marking a year-over-year increase of 185.20%. This contributed to the annual value of $4.4 million for FY2024, which is 113.60% up from last year.
  • Per Fortress Biotech's latest filing, its Treasury Shares stood at $4.4 million for FY2024, which was up 113.60% from $2.1 million recorded in FY2023.
  • Fortress Biotech's Treasury Shares' 5-year high stood at $18.1 million during FY2021, with a 5-year trough of $1.4 million in FY2022.
  • For the 3-year period, Fortress Biotech's Treasury Shares averaged around $2.6 million, with its median value being $2.1 million (2023).
  • Its Treasury Shares has fluctuated over the past 5 years, first plummeted by 92.41% in 2022, then skyrocketed by 113.60% in 2024.
  • Over the past 5 years, Fortress Biotech's Treasury Shares (Yearly) stood at $15.5 million in 2020, then climbed by 16.46% to $18.1 million in 2021, then slumped by 92.41% to $1.4 million in 2022, then surged by 50.86% to $2.1 million in 2023, then surged by 113.60% to $4.4 million in 2024.